A new study by heart researchers at Intermountain Health in Salt Lake City finds that patients with heart disease, specifically those with heart failure, are especially vulnerable to the impacts of ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not ...

In March, newly installed Social Security chief Martin O'Malley criticized agency "injustices" that "shock our shared sense of equity and good conscience as Americans." ...

People with larger bodies commonly face a pervasive, resilient form of social stigma, often facing discrimination in the workplace as well as in educational and healthcare settings.

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Researchers reveal that spermidine-mediated acetylhypusination of RIPK1 suppresses necroptosis and insulin resistance, ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR ...

GHRH and its agonists have been implicated in several cardiovascular, metabolic, and nervous system conditions. For example, ...

Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a ...

Older adults and analytical thinkers excel at discerning true from false news, while ideological biases and political ...